Add BrightSurf on Google Email

New test can help patients with cystic fibrosis

Researchers developed a simple urine test to measure cystic fibrosis severity and assess treatment effects. The test reveals the extent to which new treatments are beneficial, correlating with disease severity and lung function.

SourceAarhus University·JournalAnnals of Internal Medicine·TypeRandomized controlled/clinical trial·DateNov 14, 2022

Dartmouth study offers new insights into genetic mutations in autism disorders and points to possible treatments

A Dartmouth study reveals that disruptions in the mTORC1 pathway can rescue neuronal overgrowth and synapse function dysregulated by Pten loss, potentially offering new treatments for autism spectrum disorders. The research team also found that administering Rapamycin to children showed some benefit to symptoms of autism.

SourceThe Geisel School of Medicine at Dartmouth·JournalCell Reports·TypeExperimental study·DateNov 1, 2022

New gene editing strategy could lead to treatments for people born with inherited diseases of the immune system

Researchers have developed a pioneering gene editing strategy that can repair faulty genes in immune cells, offering new hope for patients with conditions like CTLA-4 insufficiency. The technique uses CRISPR/Cas9 to target and correct the faulty gene, preserving important regulatory mechanisms.

SourceUniversity College London·JournalScience Translational Medicine·TypeExperimental study·DateOct 26, 2022

Zinc could treat a rare genetic disorder

Researchers discovered that zinc can restore the functioning of proteins affected by mutations in the GNAO1 gene, leading to severe mental and motor disabilities. By reactivating hydrolysis, zinc enables neurons to communicate correctly with their environment.

SourceUniversité de Genève·JournalScience Advances·TypeNews article·DateOct 10, 2022

Scientists chase down what motor proteins deliver to healthy cells to find what’s altered in neurological diseases

Researchers investigate how motor proteins transport vital proteins and RNAs to the right location within cells, where they can cause or prevent genetic neurological diseases. By understanding these highly regulated transport systems, scientists hope to develop new treatments for conditions like spinal muscular atrophy and Charcot-Mari...

New UCI-led report illustrates potential of precision genome editing in treating inherited retinal diseases

Researchers at UCI have made significant progress in precision genome editing for treating inherited retinal diseases, enabling precise gene correction and disease rescue. The study highlights the potential of this technology to revolutionize treatment of genetic disorders of vision, with over 270 causative genes identified.

SourceUniversity of California - Irvine·JournalProceedings of the National Academy of Sciences·DateSep 23, 2022

Why does fasting reduce seizures?

A new study published in Cell Reports has identified the molecular pathways responsible for reduced seizures during fasting. The researchers found that amino acid sensing plays a critical role in the beneficial effects of fasting on seizures, suggesting targeted dietary strategies may be effective for patients without DEPDC5 mutations.

SourceBoston Children's Hospital·JournalCell Reports·DateSep 8, 2022

Interactions between genetics and the environment can explain variability seen in common neuropsychiatric disorders

Researchers used data from over 400,000 individuals to model genetic and environmental factors influencing common neuropsychiatric disorders. Gene-environment interactions accounted for a significant proportion of variability in some disorders, while others showed more substantial contributions.

SourceUniversity of Chicago Medical Center·JournalCell Reports Medicine·DateSep 7, 2022

New study suggests ketamine may be an effective treatment for children with ADNP syndrome

A new study suggests that low-dose ketamine is generally safe and effective in treating clinical symptoms of children diagnosed with ADNP syndrome, a rare neurodevelopmental disorder. The treatment resulted in improvements in social behavior, attention deficit, and hyperactivity, as well as reduced aggression.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalHuman Genetics and Genomics Advances·TypeExperimental study·DateSep 6, 2022

Taste sensors keep proteins in order in flies

A set of genes promoting sweet taste sensation also regulate protein management in flies, according to a new study. The finding suggests a connection between taste-related genes and disorders of protein aggregation.

SourcePLOS·JournalPLOS Biology·TypeExperimental study·DateJul 21, 2022

Lumasiran shows efficacy in adults with reduced GFR and primary hyperoxaluria type 1 (PH1)

Lumasiran, an RNA interference therapeutic, has been shown to reduce oxalate levels in patients with primary hyperoxaluria type 1 (PH1) who have relatively preserved kidney function. In the ILLUMINATE-C study, lumasiran resulted in substantial reductions in plasma oxalate with acceptable safety in patients on hemodialysis.

SourceNational Kidney Foundation·JournalAmerican Journal of Kidney Diseases·DateJul 14, 2022

Johns Hopkins researchers call for closing gap in collecting racial and ethnic data in studies of rare genetic condition

A systematic review of US-based studies on Hereditary Hemorrhagic Telangiectasia (HHT) reveals a lack of racial and ethnic data, potentially impacting treatment and diagnosis. The study highlights the need for inclusive research designs to address growing concerns about racial disparities in HHT care.

SourceJohns Hopkins Medicine·JournalOrphanet Journal of Rare Diseases·DateJul 11, 2022

Common antiretroviral drug improves cognition in mouse model of Down syndrome

Researchers found that lamivudine improved cognition in a mouse model of Down syndrome, which could lead to new pharmacological treatments for cognitive impairment. The study highlights the potential of targeting retrotransposons, segments of DNA that contribute to neurodegenerative diseases.

SourceCenter for Genomic Regulation·JournalJournal of Cellular and Molecular Medicine·TypeExperimental study·DateJun 28, 2022

Scientists discover new genetic disease that delays brain development in children

A new genetic disease has been identified that causes abnormal brain development in children, resulting in severe learning difficulties. Researchers have discovered the underlying cause of the condition by analyzing changes in a protein coding gene called GRIA1, which helps move electrical signals around the brain.

SourceUniversity of Portsmouth·JournalAmerican Journal of Human Genetics·TypeExperimental study·DateJun 24, 2022

Population bottlenecks that reduced genetic diversity were common throughout human history

A new analysis of ancient and contemporary genomes shows that more than half of historical groups experienced founder events, leading to reduced genetic diversity. This research has significant implications for scientists studying human genetic variation and the discovery of disease-causing mutations.

SourceUniversity of California - Berkeley·JournalPLOS Genetics·TypeData/statistical analysis·DateJun 23, 2022

Suspect factor for hereditary brain disease

A team of researchers has identified a key player in the molecular pathogenesis of spinocerebellar ataxia type 17 (SCA17), a rare and devastating hereditary brain disease. The enzyme calpain is found to be overactive in cell and animal models of SCA17, leading to impaired protein function and accumulation of toxic protein fragments.

SourceRuhr-University Bochum·JournalCellular and Molecular Life Sciences·TypeExperimental study·DateJun 21, 2022